Search Press releases Keywords From To 26 Jul 2005 CIMZIA(TM) demonstrates significant positive results in its two pivotal phase III Crohn's disease trials Read More 25 Jul 2005 UCB Receives Positive Opinion from European Authorities for Orphan Designation of Brivaracetam for the Treatment of Progressive Myoclonic Epilepsies Read More 20 Jul 2005 UCB Confirms Solid First Half Zyrtec Sales in USA Read More 6 Jul 2005 UCB sells its food diagnostics business to Neogen Read More 29 Jun 2005 Positive opinion for UCB's Xyrem® for the treatment of cataplexy in adults with narcolepsy Read More 24 Jun 2005 FDA Approves UCB's Keppra® for Use in Childhood Epilepsy Read More Pagination First page Previous page Previous … Page 185 Page 186 Page 187 Page 188 Current page 189 Page 190 Page 191 Page 192 Page 193 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
